By improving insulin sensitivity, promoting weight loss, and restoring glucose metabolism, GLP-1 RAs engage biological pathways relevant to both mood dysregulation and metabolic syndrome [8,63,72]. This evidence concerns the gene INS and metabolic syndrome.